Massively Parallel Reporter Assays for High-Throughput In Vivo Analysis of Cis-Regulatory Elements

The rapid improvement of descriptive genomic technologies has fueled a dramatic increase in hypothesized connections between cardiovascular gene expression and phenotypes. However, in vivo testing of these hypotheses has predominantly been relegated to slow, expensive, and linear generation of genet...

Full description

Bibliographic Details
Main Authors: Yanjiang Zheng, Nathan J. VanDusen
Format: Article
Language:English
Published: MDPI AG 2023-03-01
Series:Journal of Cardiovascular Development and Disease
Subjects:
Online Access:https://www.mdpi.com/2308-3425/10/4/144
_version_ 1797604946115297280
author Yanjiang Zheng
Nathan J. VanDusen
author_facet Yanjiang Zheng
Nathan J. VanDusen
author_sort Yanjiang Zheng
collection DOAJ
description The rapid improvement of descriptive genomic technologies has fueled a dramatic increase in hypothesized connections between cardiovascular gene expression and phenotypes. However, in vivo testing of these hypotheses has predominantly been relegated to slow, expensive, and linear generation of genetically modified mice. In the study of genomic <i>cis</i>-regulatory elements, generation of mice featuring transgenic reporters or <i>cis</i>-regulatory element knockout remains the standard approach. While the data obtained is of high quality, the approach is insufficient to keep pace with candidate identification and therefore results in biases introduced during the selection of candidates for validation. However, recent advances across a range of disciplines are converging to enable functional genomic assays that can be conducted in a high-throughput manner. Here, we review one such method, massively parallel reporter assays (MPRAs), in which the activities of thousands of candidate genomic regulatory elements are simultaneously assessed via the next-generation sequencing of a barcoded reporter transcript. We discuss best practices for MPRA design and use, with a focus on practical considerations, and review how this emerging technology has been successfully deployed in vivo. Finally, we discuss how MPRAs are likely to evolve and be used in future cardiovascular research.
first_indexed 2024-03-11T04:54:03Z
format Article
id doaj.art-6c797dbd123244c0bfc7fcd3649b81c1
institution Directory Open Access Journal
issn 2308-3425
language English
last_indexed 2024-03-11T04:54:03Z
publishDate 2023-03-01
publisher MDPI AG
record_format Article
series Journal of Cardiovascular Development and Disease
spelling doaj.art-6c797dbd123244c0bfc7fcd3649b81c12023-11-17T19:47:26ZengMDPI AGJournal of Cardiovascular Development and Disease2308-34252023-03-0110414410.3390/jcdd10040144Massively Parallel Reporter Assays for High-Throughput In Vivo Analysis of Cis-Regulatory ElementsYanjiang Zheng0Nathan J. VanDusen1Key Laboratory of Birth Defects and Related Diseases of Women and Children of MOE, Department of Pediatrics, West China Second University Hospital, Sichuan University, Chengdu 610041, ChinaDepartment of Pediatrics, Herman B Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202, USAThe rapid improvement of descriptive genomic technologies has fueled a dramatic increase in hypothesized connections between cardiovascular gene expression and phenotypes. However, in vivo testing of these hypotheses has predominantly been relegated to slow, expensive, and linear generation of genetically modified mice. In the study of genomic <i>cis</i>-regulatory elements, generation of mice featuring transgenic reporters or <i>cis</i>-regulatory element knockout remains the standard approach. While the data obtained is of high quality, the approach is insufficient to keep pace with candidate identification and therefore results in biases introduced during the selection of candidates for validation. However, recent advances across a range of disciplines are converging to enable functional genomic assays that can be conducted in a high-throughput manner. Here, we review one such method, massively parallel reporter assays (MPRAs), in which the activities of thousands of candidate genomic regulatory elements are simultaneously assessed via the next-generation sequencing of a barcoded reporter transcript. We discuss best practices for MPRA design and use, with a focus on practical considerations, and review how this emerging technology has been successfully deployed in vivo. Finally, we discuss how MPRAs are likely to evolve and be used in future cardiovascular research.https://www.mdpi.com/2308-3425/10/4/144MPRAtranscriptional regulationfunctional genomicscardiovasculardevelopment
spellingShingle Yanjiang Zheng
Nathan J. VanDusen
Massively Parallel Reporter Assays for High-Throughput In Vivo Analysis of Cis-Regulatory Elements
Journal of Cardiovascular Development and Disease
MPRA
transcriptional regulation
functional genomics
cardiovascular
development
title Massively Parallel Reporter Assays for High-Throughput In Vivo Analysis of Cis-Regulatory Elements
title_full Massively Parallel Reporter Assays for High-Throughput In Vivo Analysis of Cis-Regulatory Elements
title_fullStr Massively Parallel Reporter Assays for High-Throughput In Vivo Analysis of Cis-Regulatory Elements
title_full_unstemmed Massively Parallel Reporter Assays for High-Throughput In Vivo Analysis of Cis-Regulatory Elements
title_short Massively Parallel Reporter Assays for High-Throughput In Vivo Analysis of Cis-Regulatory Elements
title_sort massively parallel reporter assays for high throughput in vivo analysis of cis regulatory elements
topic MPRA
transcriptional regulation
functional genomics
cardiovascular
development
url https://www.mdpi.com/2308-3425/10/4/144
work_keys_str_mv AT yanjiangzheng massivelyparallelreporterassaysforhighthroughputinvivoanalysisofcisregulatoryelements
AT nathanjvandusen massivelyparallelreporterassaysforhighthroughputinvivoanalysisofcisregulatoryelements